横断面影像阴性原发性醛固酮增多症的病理组织学分类
该研究回顾性分析25例横断面影像阴性的原发性醛固酮增多症病例,通过CYP11B2免疫组化和类固醇生成酶免疫组化进行组织病理学分类,并检测醛固酮驱动基因体细胞突变。结果显示病例可分为多发性肾上腺皮质微结节(MN,n=13)和球状带弥漫性增生(DH,n=12),MN中CYP11B2阳性微结节常见CACNA1D等醛固酮驱动基因突变,提示MN可能是与醛固酮生成细胞簇相关的组织学实体。
要点
- 横断面影像阴性原发性醛固酮增多症可经形态学与CYP11B2免疫组化分为多发性微结节和球状带弥漫性增生。
- 多发性微结节中81%(21/26)的CYP11B2阳性微结节检出醛固酮驱动基因体细胞突变,以CACNA1D最常见。
- 球状带弥漫性增生中仅17%(1/6)结节检出CACNA1D突变,非结节性弥漫增生区未检出突变。
核心结论
- 形态学评估联合CYP11B2免疫组化可将横断面影像阴性原发性醛固酮增多症分为多发性肾上腺皮质微结节和球状带弥漫性增生。
- 多发性微结节中的微结节常见驱动醛固酮过度产生的体细胞突变,提示其可能是与醛固酮生成细胞簇发生相关的组织学实体。
研究设计与样本
- 回顾性分析25例横断面影像阴性原发性醛固酮增多症病例。
- 采用类固醇生成酶免疫组化评估肾上腺原位醛固酮产生能力,并对CYP11B2免疫阳性区域(n=35;微结节n=32;球状带n=3)行显微切割后二代测序检测ATP1A1、ATP2B3、CACNA1D和KCNJ5体细胞突变。
主要发现
- 根据组织病理学评估和CYP11B2免疫组化,13例归类为多发性肾上腺皮质微结节,12例归类为球状带弥漫性增生。
- 多发性微结节中26个CYP11B2阳性皮质微结节有21个(81%)检出醛固酮驱动基因体细胞突变:CACNA1D 17个(65%),KCNJ5 2个(8%),ATP1A1和ATP2B各1个(各4%)。
- 球状带弥漫性增生中6个结节有1个(17%)检出CACNA1D体细胞突变,CYP11B2阳性非结节性弥漫增生区域未检出突变。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Approximately half of patients with primary aldosteronism (PA) have clinically evident disease according to clinical (hypertension) and/or laboratory (aldosterone and renin levels) findings but do not have nodules detectable in routine cross-sectional imaging. However, the detailed histopathologic, steroidogenic, and pathobiological features of cross-sectional image-negative PA are controversial. OBJECTIVE: To examine histopathology, steroidogenic enzyme expression, and aldosterone-driver gene somatic mutation status in cross-sectional image-negative hyperaldosteronism. METHODS: Twenty-five cross-sectional image-negative cases were retrospectively reviewed. In situ adrenal aldosterone production capacity was determined using immunohistochemistry (IHC) of steroidogenic enzymes. Aldosterone-driver gene somatic mutation status (ATP1A1, ATP2B3, CACNA1D, and KCNJ5) was determined in the CYP11B2 immunopositive areas [n = 35; micronodule, n = 32; zona glomerulosa (ZG), n = 3] using next-generation sequencing after macrodissection. RESULTS: Cases were classified as multiple adrenocortical micronodules (MN; n = 13) or diffuse hyperplasia (DH) of ZG (n = 12) based upon histopathological evaluation and CYP11B2 IHC. Aldosterone-driver gene somatic mutations were detected in 21 of 26 (81%) of CYP11B2-positive cortical micronodules in MN; 17 (65%) mutations were in CACNA1D, 2 (8%) in KCNJ5, and 1 each (4% each) in ATP1A1 and ATP2B. One of 6 (17%) of nodules in DH harbored somatic aldosterone-driver gene mutations (CACNA1D); however, no mutations were detected in CYP11B2-positive nonnodular DH areas. CONCLUSION: Morphologic evaluation and CYP11B2 IHC enabled the classification of cross-sectional image-negative hyperaldosteronism into MN and DH. Somatic mutations driving aldosterone overproduction are common in micronodules of MN, suggesting a histological entity possibly related to aldosterone-producing cell cluster development.
引用
- Yamazaki Y, Nakamura Y, Omata K, et al. Histopathological Classification of Cross-Sectional Image-Negative Hyperaldosteronism. J Clin Endocrinol Metab. 2017. PMID: 28388725. doi:10.1210/jc.2016-2986
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。